一个透驱动的3D打印脑植入物用于药物输送
Ata Ullah1, Jade Bookwalter1, Himanshu Sant2
1Department of Biomedical Engineering, The University of Utah, 36 Wasatch Dr., SMBB 3100, Salt Lake City, UT, 84112, USA.
Biomedical microdevices
|June 16, 2025
概括
这项研究引入了一种新的3D打印脑植入物,用于质母细胞瘤治疗. 透驱动装置提供定制的药物输送直接到瘤部位,改善治疗结果和减少全身毒性.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 由于手术的局限性,高复发率和无效的全身药物输送,质母细胞瘤存在重大治疗挑战.
- 现有的脑植入物往往由于技术问题失败,如堵塞和反流,治疗效果有限.
- 需要先进的药物输送系统来提高质母细胞瘤患者的生存率.
研究的目的:
- 开发和表征一种创新的透驱动的3D打印脑植入物,用于局部化质母细胞瘤治疗.
- 为了能够精确地根据个体治疗需求定制植入物,并避免系统性毒性.
- 评估植入物的药物输送能力,包括流量和扩散距离.
主要方法:
- 设计了一种由透驱动的3D打印脑部植入物,具有双水库和精密工程针.
- 在体外表征过程中,我们使用阿加凝作为大脑组织模拟物,食品染料作为药物模拟物,化作为化物.
- 实验的设计方法优化参数,如膜孔大小,氧化物度和针的长度.
主要成果:
- 优化的植入物表现出可控释放率,流量为2.5 ± 0.1μl/小时.
- 在大脑组织模拟体内达到高达15.5 ± 0.4毫米的显著扩散距离.
- 使用25纳米孔异位膜和25.3%的异位素度实现了最佳性能.
结论:
- 开发的3D打印脑植入物为局部质母细胞瘤治疗提供了一个有前途的解决方案.
- 透驱动的机制允许精确控制药物释放和延长治疗时间.
- 这项技术有可能克服当前治疗方法的局限性,并改善患者的治疗结果.
更多相关视频
10:32Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
Published on: January 18, 2016
14.3K
06:07Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
Published on: December 17, 2021
5.1K
相关概念视频
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...